STATESVILLE, N.C., Aug. 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended July 31, 2005 .

Net earnings for the quarter were $763,000 , or $0.31 per diluted share. Excluding a gain on the sale of property, net earnings for the quarter were $223,000 , or $0.09 per diluted share, as compared to net earnings of $193,000 , or $0.08 per diluted share, in the same quarter last year. The previously reported sale of the Company's plant site in Lockhart, Texas resulted in an after-tax gain of $540,000 , or $0.22 per diluted share.

Sales for the quarter were $20,308,000 , slightly above sales of $20,288,000 in the same period last year, and 5.7% above the previous quarter. The laboratory furniture marketplace continued its improvement during the quarter. The favorable impact of this improved marketplace on sales and earnings was partially offset by a softer marketplace for technical furniture. Order activity continued to improve, as in-coming orders of $20.4 million were the highest level in the past five quarters. The order backlog at July 31, 2005 increased to $40.7 million , as compared to $39.6 million at July 31, 2004 , and was up slightly from April 30, 2005 .

The Company's balance sheet remains strong. Total debt at July 31, 2005 was $6.1 million , down from $9.8 million at July 31, 2004 , while cash on hand at the end of the quarter was $1.0 million . Book value per share was $10.66 at July 31, 2005 .

'The laboratory furniture marketplace continues to improve,' said William A. Shumaker, President and Chief Executive Officer. 'Our recent quoting activity for projects over $1 million is the highest in several years. Although larger projects have delivery dates usually between 6-18 months from the order award date, this increased activity bodes well for the long-term. Our efforts to reduce raw material costs have been successful in obtaining more competitive pricing from new and existing suppliers, and we are aggressively expanding this effort.

'Looking forward,' Mr. Shumaker continued, 'We expect progress to continue in most of our markets for the remainder of the fiscal year. The gradual improvement of the laboratory furniture market is projected to continue, but we do not yet see a strong improvement in sales for our technical furniture business. Our subsidiaries in India and Singapore continue to grow and contribute nicely, though modestly, to our sales and profits. We are particularly pleased to see improvement in the Singapore marketplace, which has been soft the past year.'

The Company also announced today that its Board of Directors approved a cash dividend of seven cents per outstanding share to stockholders of record at the close of business on September 8, 2005 , payable on September 23, 2005 .

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters and manufacturing facilities are located in Statesville, North Carolina. The Company also has subsidiaries in Singapore and Bangalore , India that serve the Asian markets. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute 'forward-looking' statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.

     Contact:  D. Michael Parker
               704/871-3290



       Condensed Consolidated Statements of Operations [unaudited]
                    (in thousands, except per share data)

                                         Three Months Ended
                                       July 31         July 31
                                         2005            2004


     Net sales                         $20,308          $20,288
     Cost of products sold              16,922           16,912

     Gross profit                        3,386            3,376
     Operating expenses                  2,920            3,046

     Operating earnings                    466              330
     Other income                          879               46
     Interest expense                      (87)             (86)

     Earnings before income taxes        1,258              290
     Income tax expense                    457              100

     Earnings before minority interests    801              190
     Minority interests                     38               (3)
     Net earnings                        $763*             $193

     Net earnings per share
           Basic                         $0.31            $0.08
           Diluted                       $0.31            $0.08

     Weighted average number of common
      shares outstanding (in thousands)
           Basic                         2,492            2,490
           Diluted                       2,492            2,500

* Includes a non-recurring after-tax gain on the sale of property in the amount of $540,000 , or $.22 per diluted share.



                    Condensed Consolidated Balance Sheets
                    (in thousands, except per share data)

                                                 July 31      April 30
                                                   2005         2005
    Assets                                      [unaudited]

    Cash and cash equivalents                      $646         $225
    Restricted cash                                 373          379
    Receivables, less allowances                 21,231       21,683
    Inventories                                   4,938        3,542
    Prepaid expenses and other current assets     1,237          951
       Total current assets                      28,425       26,780
    Net property, plant and equipment            11,140       10,730
    Other assets                                  7,328        8,702
    Total Assets                                $46,893      $46,212

    Liabilities and Stockholders' Equity
    Short-term borrowings                        $5,038       $3,778
    Current portion of long-term debt               652          931
    Current obligations under capital leases        114          111
    Accounts payable                              7,443        8,558
    Other current liabilities                     3,219        3,021
       Total current liabilities                 16,466       16,399
    Other non-current liabilities                 3,852        3,824
    Total stockholders' equity                   26,575       25,989
    Total Liabilities and Stockholders' Equity  $46,893      $46,212

SOURCE Kewaunee Scientific Corporation